Exchange: NASDAQ·Updated 11:20 AM EDT
LXRX logo

LXRX Lexicon Pharmaceuticals Inc

$1.94
$0.12
(5.83%)
Today
EarningsNov 5
Mkt Cap$916.61M
Vol1.27M

About LXRX

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.
51

Neutral Sentiment

How do you feel about LXRX?

Advertisement|Remove ads.